Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Operating Leases: 2021-2024

Historic Operating Leases for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $37.2 million.

  • Prime Medicine's Operating Leases rose 186.40% to $118.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.1 million, marking a year-over-year increase of 186.40%. This contributed to the annual value of $37.2 million for FY2024, which is 753.34% up from last year.
  • According to the latest figures from FY2024, Prime Medicine's Operating Leases is $37.2 million, which was up 753.34% from $4.4 million recorded in FY2023.
  • Prime Medicine's 5-year Operating Leases high stood at $37.2 million for FY2024, and its period low was $3.1 million during FY2021.
  • Moreover, its 3-year median value for Operating Leases was $17.1 million (2022), whereas its average is $19.5 million.
  • Per our database at Business Quant, Prime Medicine's Operating Leases slumped by 74.45% in 2023 and then spiked by 753.34% in 2024.
  • Prime Medicine's Operating Leases (Yearly) stood at $3.1 million in 2021, then surged by 455.41% to $17.1 million in 2022, then crashed by 74.45% to $4.4 million in 2023, then soared by 753.34% to $37.2 million in 2024.